+966 568813716 [email protected]

The Blog

Home / Page 3
30
Aug
2024
The murderer Case report
Posted On August 30, 2024  By [email protected]  And has No Comment

Read More

02
Aug
2024
Esketamine nasal spray: New hope for resistant depression
Posted On August 2, 2024  By [email protected]  And has No Comment

On March 05, 2019 The U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepresant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk […]

Read More

02
Aug
2024
Buvidal : a new hope for opiate addiction?
Posted On August 2, 2024  By [email protected]  And has No Comment

What is Opioid Agonist Treatment (OAT)? Here’s a general medical protocol for using Buvidal (long-acting buprenorphine) in a day case hospitalization setting for an opioid-dependent patient. Please note that this should be adapted based on specific institutional guidelines and individual patient needs. Suggested Protocol for Buvidal […]

Read More

13
Jul
2024
Normal Pressure Hydrocephalus:
Posted On July 13, 2024  By [email protected]  And has No Comment

Etiology and Course of illness : What causes normal pressure hydrocephalus? NPH occurs if the normal flow of CSF throughout the brain and spinal cord is blocked in some way. This may be due to past injury, bleeding, infection, brain tumor, or surgery on the brain, […]

Read More

07
Jun
2024
Dopamine receptors in the brain
Posted On June 7, 2024  By [email protected]  And has No Comment

Dopamine receptors are widely distributed throughout the brain and play crucial roles in various neurological processes. Here’s an overview of the functions and locations of different dopamine receptor subtypes in the brain: It’s important to note that dopamine receptors often work in concert with each other […]

Read More

06
Jun
2024
Lewy Body Dementia
Posted On June 6, 2024  By [email protected]  And has No Comment

The Dementia with Lewy Bodies Consortium released in 2017 a refined set of diagnostic criteria (McKeith et al, 2017). Whereas like other neurodegenerative diseases, the “definite” diagnostic category can only be used after posthumous pathological examination, the “probable” category can be readily used in clinical practice. […]

Read More

02
Jun
2024
وأخيرا عقار اونيدا ( هيدروكلوريد الكلونيدين )
Posted On June 2, 2024  By [email protected]  And has No Comment

وافقت إدارة الغذاء والدواء الأمريكية (FDA) على Onyda XR (هيدروكلوريد الكلونيدين) لعلاج اضطراب فرط الحركة و نقص الانتباه عقار (ADHD)، حسبما أعلنت شركة تصنيع الأدوية Tris Pharma في بيان. الدواء هو أول دواء سائل غير محفز لاضطراب فرط الحركة ونقص الانتباه. يمكن استخدام الشراب عن طريق […]

Read More

01
Jun
2024
Psychiatric Interviewing
Posted On June 1, 2024  By [email protected]  And has No Comment

Introduction Several students while they study psychiatry they face a problem of remembering and presentation of the read material as well as the clinical presentation of a case. This little book is a trial to help for better performance. Many medical students use mnemonics as a […]

Read More

23
May
2024
The Story of ECT
Posted On May 23, 2024  By [email protected]  And has No Comment

Electroconvulsive therapy (ECT), formerly known as electroshock therapy, is a psychiatric treatment that involves inducing a brief seizure in the patient by passing electric currents through the brain. It has a long and controversial history, with both proponents and critics. The origins of ECT can be […]

Read More

12
May
2024
The story of discovery of aripiprazole molecule?
Posted On May 12, 2024  By [email protected]  And has No Comment

Aripiprazole is an atypical antipsychotic medication that was discovered and developed by Otsuka Pharmaceutical Company, a Japanese pharmaceutical company, in the late 1980s and early 1990s. The story of the discovery of the aripiprazole molecule began with the search for a new antipsychotic drug that would […]

Read More

Page 3 of 90